Immunological Linkages Between Inflammatory Bowel Diseases and Type 2 Diabetes

Area of Science:

• Immunology
• Gastroenterology
• Endocrinology

Background:

• Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic immune-mediated gastrointestinal disorders.
• IBDs involve dysregulated immune responses to gut microbiota, leading to inflammation and tissue damage, often with comorbidities.
• Type 2 diabetes (T2D) also involves chronic low-grade inflammation and immune pathway alterations.

Purpose of the Study:

• To investigate the pathophysiological link and clinical association between IBD and T2D.
• To determine if specific IBD subtypes (UC or CD) have a stronger association with T2D.
• To explore potential age-related patterns in the co-occurrence of IBD and T2D.

Main Methods:

• A cohort study of 49 patients diagnosed with both IBD and T2D.
• A matched case-control analysis comparing 48 IBD-T2D cases with 96 controls.
• Analysis of IBD subtype prevalence (UC, CD) within the IBD-T2D cohort.

Main Results:

• A strong correlation was found between IBD and T2D.
• Ulcerative colitis (UC) was the predominant IBD subtype associated with T2D, accounting for over 70% of cases in both study designs.
• The highest prevalence of IBD-T2D co-occurrence was observed in the 65-74 age group; Crohn's disease (CD) was notably absent in the 55-64 age group.

Conclusions:

• Ulcerative colitis (UC) demonstrates a stronger immunological and clinical association with type 2 diabetes (T2D) compared to Crohn's disease (CD).
• Immune dysregulation is a shared underlying factor for both IBD and T2D.
• UC may act as an immunological bridge connecting gastrointestinal and metabolic inflammation.